Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of an eXtended and proacTive Dosing regimEn in Treatment-Naïve Patients With Wet Age-related Macular Degeneration (wAMD)

NCT03939767 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT03939767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03939767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of an eXtended and proacTive Dosing regimEn in Treatment-Naïve Patients With Wet Age-related Macular Degeneration (wAMD)
Lead sponsor
Bayer
Phase
Observational
Overall status
Completed
Start date
May 12, 2019
Completion date
October 17, 2023
Enrollment
1,563 (actual)
Sites
17

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration